Objective: The benefit of using smartphones for hearing tests in a non-supervised, rapid, and contactless way has drawn a lot of interest, especially if supra-threshold measures are assessed that go beyond audiogram-based measures alone. It is unclear, nevertheless, how well these measures compare to more supervised and regulated manual audiometric assessments. The aim of this study is to validate such smartphone-based methods against standardized laboratory assessments. Design: Pure-tone audiometry and categorical loudness scaling (CLS) were used. Three conditions with varying degrees of supervision were created and compared. In order to assess binaural and spectral loudness summation, both narrowband monaural and broadband binaural noise have been examined as CLS test stimuli. Study sample: N = 21 individuals with normal hearing and N = 16 participants with mild-to-moderate hearing loss. Results: The tests conducted here did not show any distinctions between smartphone-based and laboratory-based methods. Conclusions: Non-supervised listening tests via smartphone may serve as a valid, reliable, and cost-effective approach, e.g., for pure-tone audiometry, CLS, and the evaluation of binaural and spectral loudness summation. In addition, the supra-threshold tests can be constructed to be invariant against missing calibration and external noise which makes them more robust for smartphone usage than audiogram measures.

The authors have declared no competing interest.

This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy EXC 2177/1 - Project ID 390895286.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The research ethics committee of the University of Oldenburg approved the proposal (Drs. EK/2022/011) for this study.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors.